Temat: "Multiple Myeloma" - OpacWWW

Стрибайте на позицію: 1.

Tytuł:: Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma.
Autorzy:: Tao Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Jin S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Yang D; Department of Hematology, Lu Daopei Hospital, 200025, Shanghai, China.
Pan M; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Ouyang W; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Liu Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Wang Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Zhang W; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China. .
Mi J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China. .; Показати більше
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 02; Vol. 24 (1), pp. 406. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/genetics
Multiple Myeloma*/therapy
Multiple Myeloma*/diagnosis
Hematopoietic Stem Cell Transplantation*
Humans ; Treatment Outcome ; Transplantation, Autologous ; Stem Cell Transplantation ; Chromosome Aberrations ; Neoplasm, Residual/diagnosis

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 2.

Tytuł:: MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis.
Autorzy:: Wang X; Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, China.; Center for Reproductive Medicine, Shengjing Hospital, China Medical University, Shenyang, China.
Shi Y; Department of Hematology, Daping Hospital, Chongqing, China.
Shi H; Shenshan Medical Center, Memorial Hospital of Sun Yat-Sen University, Shanwei, China.
Liu X; Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, China.
Liao A; Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, China.
Liu Z; Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, China.
Orlowski RZ; Departments of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Zhang R; Department of Hematology, The First Affiliated Hospital, China Medical University, Shenyang, China. .
Wang H; Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, China. .; Показати більше
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 05; Vol. 43 (1), pp. 68. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article
MeSH Terms:: Proteasome Inhibitors*/pharmacology
Multiple Myeloma*/drug therapy
Multiple Myeloma*/genetics
Humans ; Oncogenes ; Cytoplasm ; Antiviral Agents ; DNA ; DNA, Circular ; Kinesins ; Mucins

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 3.

Tytuł:: Oncolytic Myxoma virus Increases Autophagy in Multiple Myeloma
Autorzy:: Yeşilaltay A; Başkent University İstanbul Hospital, Department of Hematology, İstanbul, Türkiye
Muz D; Tekirdağ Namık Kemal University Faculty of Veterinary Medicine, Department of Virology, Tekirdağ, Türkiye
Erdal B; Tekirdağ Namık Kemal University Faculty of Medicine, Department of Microbiology, Tekirdağ, Türkiye; Показати більше
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 16-25. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:: Journal Article
MeSH Terms:: Oncolytic Viruses*
Multiple Myeloma*/therapy
Multiple Myeloma*/pathology
Myxoma virus*/genetics
Animals ; Mice ; Humans ; Beclin-1/genetics ; Cell Line, Tumor ; Autophagy

Czasopismo naukowe

на полиці

Pełny tekst Деталі

Стрибайте на позицію: 4.

Tytuł:: Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored
Autorzy:: Zhang Q; Zhejiang Provincial People’s Hospital Bijie Hospital, Department of Cardiology, Bijie, China
Wang Y; Xinchang Hospital Affiliated to Wenzhou Medical University, Department of Thoracic Surgery, Xinchang, China
Pan W; Haiyan People’s Hospital, Department of Clinical Laboratory, Haiyan, China; Показати більше
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 51-52. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/complications
Multiple Myeloma*/drug therapy
Agammaglobulinemia*/diagnosis
Agammaglobulinemia*/etiology
Agammaglobulinemia*/therapy
Humans ; Immunoglobulin G ; Immunization, Passive

Czasopismo naukowe

на полиці

Pełny tekst Деталі

Стрибайте на позицію: 5.

Tytuł:: The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study.
Autorzy:: Emery A; Department for Health, University of Bath, Bath, UK.
Moore S; Department for Haematology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Crowe J; Department for Haematology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Murray J; Department for Haematology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Peacock O; Department for Health, University of Bath, Bath, UK.
Thompson D; Department for Health, University of Bath, Bath, UK.
Betts F; Department for Health, University of Bath, Bath, UK.
Rapps S; Department for Health, University of Bath, Bath, UK.
Ross L; Department for Health, University of Bath, Bath, UK.
Rothschild-Rodriguez D; School of Biological Sciences, University of Southampton, Southampton, UK.
Arana Echarri A; Department for Health, University of Bath, Bath, UK.
Davies R; Department for Health, University of Bath, Bath, UK.
Lewis R; Department for Physiotherapy, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Augustine DX; Department for Health, University of Bath, Bath, UK.; Department for Cardiology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Whiteway A; Department for Haematology, North Bristol NHS Trust, Bristol, UK.
Afzal Z; Clinical Immunology Service, Institute of Immunity and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Heaney J; Clinical Immunology Service, Institute of Immunity and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Drayson MT; Clinical Immunology Service, Institute of Immunity and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Turner JE; Department for Health, University of Bath, Bath, UK.; School of Sport, Exercise and Rehabilitation Sciences, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
Campbell JP; Department for Health, University of Bath, Bath, UK. .; School of Medical and Health Sciences, Edith Cowan University, WA, Joondalup, Australia. .; Показати більше
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 05; Vol. 24 (1), pp. 174. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Monoclonal Gammopathy of Undetermined Significance*/therapy
Monoclonal Gammopathy of Undetermined Significance*/diagnosis
Multiple Myeloma*/diagnosis
Paraproteinemias*
Smoldering Multiple Myeloma*
Humans ; Adult ; Pilot Projects ; Quality of Life ; Disease Progression ; Biomarkers ; Exercise

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 6.

Tytuł:: Racial differences in treatment and survival among older patients with multiple myeloma.
Autorzy:: Wang R; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, Connecticut, USA.
Neparidze N; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, Connecticut, USA.; Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, Connecticut, USA.
Ma X; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, Connecticut, USA.
Colditz GA; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
Chang SH; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
Wang SY; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, Connecticut, USA.; Показати більше
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6915. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/drug therapy
Multiple Myeloma*/mortality
Healthcare Disparities*
Aged ; Humans ; Black or African American ; Databases, Factual ; Medicare ; Race Factors ; United States/epidemiology

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 7.

Tytuł:: Indisulam synergizes with melphalan to inhibit Multiple Myeloma malignancy via targeting TOP2A.
Autorzy:: Wu C; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wu C; Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jia M; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zeng X; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Fu Z; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
He Z; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu W; Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yan H; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Показати більше
Źródło:: PloS one [PLoS One] 2024 Apr 09; Vol. 19 (4), pp. e0299019. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Melphalan*/pharmacology
Melphalan*/therapeutic use
Multiple Myeloma*/drug therapy
Multiple Myeloma*/genetics
Multiple Myeloma*/pathology
Humans ; Cell Line, Tumor ; Sulfonamides/pharmacology ; Sulfonamides/therapeutic use

Czasopismo naukowe

на полиці

Pełny tekst Деталі

Стрибайте на позицію: 8.

Tytuł:: Prognostic marker CD27 and its micro-environmental in multiple myeloma.
Autorzy:: Wang X; Hematology Department, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.
Luo K; Hematology Department, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.
Xu Q; Hematology Department, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.
Chi L; Hematology Department, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.
Guo Y; Hematology Department, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.
Jia C; Hematology Department, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China. .
Quan L; Hematology Department, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China. .; Показати більше
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 19; Vol. 24 (1), pp. 352. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*
Humans ; Prognosis ; CD27 Ligand ; Bone Marrow/pathology ; Signal Transduction ; Tumor Microenvironment

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 9.

Tytuł:: Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM).
Autorzy:: Du J; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Lin Z; Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Fu XH; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Gu XR; Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lu G; Department of Hematology, Shengli Oilfield Central Hospital, Dongying, 257099, China. .
Hou J; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. .; Показати більше
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 12; Vol. 22 (1), pp. 177. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Multiple Myeloma*
Heterocyclic Compounds*
Humans ; Hematopoietic Stem Cell Mobilization ; Chemokines ; Signal Transduction ; Biomarkers

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 10.

Tytuł:: A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models.
Autorzy:: Tomita U; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Ishimoto Y; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Ri M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Kawase Y; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Hizukuri Y; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Maru C; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Nanai K; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Nakamura R; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Nakayama M; Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Oguchi-Oshima K; Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.
Sumi H; Daiichi Sankyo Co., Ltd., Tokyo, Japan. .
Ohtsuka T; Daiichi Sankyo Co., Ltd., Tokyo, Japan. .
Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Agatsuma T; Daiichi Sankyo Co., Ltd., Tokyo, Japan.; Показати більше
Źródło:: Scientific reports [Sci Rep] 2024 Mar 01; Vol. 14 (1), pp. 5135. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Antibodies, Bispecific*/therapeutic use
Multiple Myeloma*/immunology
Multiple Myeloma*/pathology
Multiple Myeloma*/therapy
Humans ; Cytokines/metabolism ; Immunomodulating Agents ; Receptors, G-Protein-Coupled ; T-Lymphocytes

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 11.

Tytuł:: The Role of Bone Marrow Biopsy Evaluation in the Workup for Monoclonal Gammopathy of Renal Significance: A Diagnosis of Exclusion.
Autorzy:: Metcalf BD; From the Department of Pathology (Metcalf, Huang, Kanaan, Li, Zhang).
Huang J; From the Department of Pathology (Metcalf, Huang, Kanaan, Li, Zhang).
Kanaan HD; From the Department of Pathology (Metcalf, Huang, Kanaan, Li, Zhang).
Abukhaled J; the Division of Nephrology (Abukhaled, Zarouk).
Li W; From the Department of Pathology (Metcalf, Huang, Kanaan, Li, Zhang).
Samarapungavan D; and the Multi-organ Transplant Center (Samarapungavan).
Zarouk S; the Division of Nephrology (Abukhaled, Zarouk).
Zhang PL; From the Department of Pathology (Metcalf, Huang, Kanaan, Li, Zhang).; Показати більше
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Mar 01; Vol. 148 (3), pp. e57-e62.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/diagnosis
Multiple Myeloma*/pathology
Paraproteinemias*/diagnosis
Monoclonal Gammopathy of Undetermined Significance*/diagnosis
Monoclonal Gammopathy of Undetermined Significance*/pathology
Kidney Diseases*/diagnosis
Kidney Diseases*/etiology
Kidney Diseases*/pathology
Humans ; Bone Marrow/pathology ; Kidney/pathology ; Biopsy

Czasopismo naukowe

на полиці

Pełny tekst Деталі

Стрибайте на позицію: 12.

Tytuł:: The Many Faces of Multiple Myeloma
Autorzy:: Bol AT; Ankara University Faculty of Medicine, Department of Pathology, Ankara, Türkiye
Cengiz Seval G; Ankara University Faculty of Medicine, Department of Hematology, Ankara, Türkiye
Beksaç M; Ankara University Faculty of Medicine, Department of Hematology, Ankara, Türkiye
Kuzu I; Ankara University Faculty of Medicine, Department of Pathology, Ankara, Türkiye; Показати більше
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 41-42. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/diagnosis
Multiple Myeloma*/therapy
Humans

Czasopismo naukowe

на полиці

Pełny tekst Деталі

Стрибайте на позицію: 13.

Tytuł:: Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study.
Autorzy:: Choi S; Department of Pharmacology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul, Republic of Korea.; Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Kim E; Department of Pharmacology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul, Republic of Korea.; Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Jung J; Department of Pharmacology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul, Republic of Korea.; Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Park SS; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Catholic Research Network for Multiple Myeloma, Seoul, Republic of Korea.
Min CK; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Catholic Research Network for Multiple Myeloma, Seoul, Republic of Korea.
Han S; Department of Pharmacology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul, Republic of Korea. .; Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. .; Показати більше
Źródło:: Scientific reports [Sci Rep] 2024 Feb 28; Vol. 14 (1), pp. 4885. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/diagnosis
Multiple Myeloma*/epidemiology
Humans ; Cohort Studies ; Social Class ; Risk Factors ; Risk Assessment

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 14.

Tytuł:: Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes.
Autorzy:: Wang YH; Department of Hematology, Tokyo Women's Medical University, 8-1, Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, Japan.
Hagiwara S; Department of Hematology, Tokyo Women's Medical University, 8-1, Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, Japan.
Kazama H; Department of Hematology, Tokyo Women's Medical University, 8-1, Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, Japan.; Department of Medicine, Tokyo Women's Medical University, Adachi Medical Center, 4-33-1, Kohoku, Adachi-Ku, Tokyo 123-8558, Japan.
Iizuka Y; Department of Hematology, Tokyo Women's Medical University, 8-1, Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, Japan.
Tanaka N; Department of Hematology, Tokyo Women's Medical University, 8-1, Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, Japan.
Tanaka J; Department of Hematology, Tokyo Women's Medical University, 8-1, Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, Japan.; Показати більше
Źródło:: Journal of immunology research [J Immunol Res] 2024 Feb 27; Vol. 2024, pp. 1429879. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Leukocytes, Mononuclear*
Multiple Myeloma*/genetics
Multiple Myeloma*/therapy
Humans ; Antibodies, Monoclonal, Humanized/pharmacology ; Tumor Necrosis Factor-alpha

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 15.

Tytuł:: Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.
Autorzy:: Torcasio R; Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Viale Europa, Campus Germaneto, 88100, Catanzaro, Italy.; Department of Biology, Ecology and Earth Sciences, University of Calabria, Cosenza, Italy.
Gallo Cantafio ME; Department of Biology, Ecology and Earth Sciences, University of Calabria, Cosenza, Italy.
Veneziano C; Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Viale Europa, Campus Germaneto, 88100, Catanzaro, Italy.
De Marco C; Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Viale Europa, Campus Germaneto, 88100, Catanzaro, Italy.
Ganino L; Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Viale Europa, Campus Germaneto, 88100, Catanzaro, Italy.
Valentino I; Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Viale Europa, Campus Germaneto, 88100, Catanzaro, Italy.
Occhiuzzi MA; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Rende, CS, Italy.
Perrotta ID; Department of Biology, Ecology and Earth Sciences, Centre for Microscopy and Microanalysis, University of Calabria, Cosenza, Italy.
Mancuso T; Annunziata' Regional Hospital Cosenza, 87100, Cosenza, Italy.
Conforti F; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Rende, CS, Italy.
Rizzuti B; SS Rende (CS), Department of Physics, CNR-NANOTEC, University of Calabria, Via Pietro Bucci, 87036, Rende, CS, Italy.; Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Unit GBsC-CSIC-BIFI, University of Zaragoza, 50018, Saragossa, Spain.
Martino EA; Annunziata' Regional Hospital Cosenza, 87100, Cosenza, Italy.
Gentile M; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Rende, CS, Italy.; Annunziata' Regional Hospital Cosenza, 87100, Cosenza, Italy.
Neri A; Scientific Directorate, IRCCS Di Reggio Emilia, Emilia Romagna, Reggio Emilia, Italy.
Viglietto G; Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Viale Europa, Campus Germaneto, 88100, Catanzaro, Italy.
Grande F; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Rende, CS, Italy.
Amodio N; Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Viale Europa, Campus Germaneto, 88100, Catanzaro, Italy. .; Показати більше
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 27; Vol. 22 (1), pp. 208. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Hesperidin*/pharmacology
Multiple Myeloma*/drug therapy
Flavanones*/pharmacology
Flavanones*/therapeutic use
Flavanones*/chemistry
Mice ; Animals ; Humans ; Mitochondrial Dynamics ; Molecular Docking Simulation ; Mice, Inbred NOD ; Mice, SCID

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 16.

Tytuł:: Rheological properties of blood in multiple myeloma patients.
Autorzy:: Ptaszek B; Institute of Applied Sciences, University of Physical Education in Krakow, 31-571, Kraków, Poland. .
Podsiadło S; Institute of Clinical Rehabilitation, University of Physical Education in Krakow, 31-571, Kraków, Poland.
Jandziś Z; Faculty of Motor Rehabilitation, University of Physical Education in Krakow, 31-571, Kraków, Poland.
Teległów A; Institute of Basic Sciences, University of Physical Education in Krakow, 31-571, Kraków, Poland.
Piotrowska A; Institute of Basic Sciences, University of Physical Education in Krakow, 31-571, Kraków, Poland.
Jurczyszyn A; Department of Hematology, Jagiellonian University Medical College, 31-501, Kraków, Poland.
Czerwińska-Ledwig O; Institute of Basic Sciences, University of Physical Education in Krakow, 31-571, Kraków, Poland.; Показати більше
Źródło:: Scientific reports [Sci Rep] 2024 Feb 21; Vol. 14 (1), pp. 4260. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Erythrocyte Deformability*
Multiple Myeloma*
Humans ; Hemorheology ; Erythrocytes ; Erythrocyte Aggregation ; Rheology ; Blood Viscosity ; Blood Sedimentation

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 17.

Tytuł:: Enhanced clinical outcomes with radiotherapy in diagnostically challenging intracranial plasmacytomas: Analysis of 190 cases.
Autorzy:: Feng Y; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Zhang Z; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Qiu F; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Yang Z; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Xiong J; Department of Pathology, Huashan Hospital, Fudan University, Shanghai, China.
Zhu W; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Wan F; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Chen B; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
Wang J; Division of Life Science, Department of Chemical and Biological Engineering, and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong SAR, China.; SIAT-HKUST Joint Laboratory of Cell Evolution and Digital Health, HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Shenzhen, China.; Hong Kong Center for Neurodegenerative Diseases, InnoHK, Hong Kong SAR, China.
Zhang Y; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Hua W; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.; Показати більше
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7017.
Typ publikacji:: Journal Article
MeSH Terms:: Plasmacytoma*/diagnostic imaging
Plasmacytoma*/radiotherapy
Multiple Myeloma*/pathology
Bone Neoplasms*/pathology
Humans ; Middle Aged ; Retrospective Studies ; Ki-67 Antigen ; Disease Progression

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 18.

Tytuł:: Cytogenetic, Clinical, Hematologic, Demographic, Immunohistochemical, and Flow Cytometry Characteristics of Patients with Plasma Cell Neoplasm in Five Years: A First Report from Iran.
Autorzy:: Shokripour M; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Hosseini SE; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Omidifar N; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mokhtari M; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Safaei A; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Показати більше
Źródło:: Iranian journal of medical sciences [Iran J Med Sci] 2024 Feb 01; Vol. 49 (2), pp. 77-87. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/pathology
Neoplasms, Plasma Cell*/diagnosis
Neoplasms, Plasma Cell*/epidemiology
Plasmacytoma*
Male ; Young Adult ; Humans ; Middle Aged ; Female ; Iran/epidemiology ; Flow Cytometry/methods ; Retrospective Studies ; Cross-Sectional Studies ; Aneuploidy ; Cytogenetic Analysis ; Demography

Czasopismo naukowe

на полиці

Pełny tekst Деталі

Стрибайте на позицію: 19.

Tytuł:: Machine learning evaluation for identification of M-proteins in human serum.
Autorzy:: Sopasakis A; Mathematics, Faculty of Engineering (LTH), Lund University, Lund, Sweden.
Nilsson M; Department of Clinical Chemistry, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Askenmo M; Department of Clinical Chemistry, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Nyholm F; Department of Clinical Chemistry, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Mattsson Hultén L; Department of Clinical Chemistry, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Rotter Sopasakis V; Department of Clinical Chemistry, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Показати більше
Źródło:: PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0299600. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Antibodies*
Multiple Myeloma*/diagnosis
Humans ; Reproducibility of Results ; Electrophoresis, Capillary ; Algorithms ; Immunoglobulin Isotypes ; Machine Learning

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Стрибайте на позицію: 20.

Tytuł:: Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database.
Autorzy:: Dixit J; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Gupta N; Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India.
Kataki A; Dr. B. Booroah Cancer Institute, Guwahati, Assam, India.
Roy P; Dr. B. Booroah Cancer Institute, Guwahati, Assam, India.
Mehra N; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India.
Kumar L; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Singh A; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Malhotra P; Department of Clinical Haematology and Medical Oncology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Gupta D; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Goyal A; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Rajsekar K; Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India.
Krishnamurthy MN; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.
Gupta S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.
Prinja S; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. .; Показати більше
Źródło:: Health and quality of life outcomes [Health Qual Life Outcomes] 2024 Mar 13; Vol. 22 (1), pp. 26. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Testicular Neoplasms*
Multiple Myeloma*
Male ; Female ; Humans ; Quality of Life ; Surveys and Questionnaires ; Educational Status

Czasopismo naukowe

на полиці

Pełny tekst Pełny tekst Деталі

Інформація

Ви шукаєте ""Multiple Myeloma"" за критеріями: Temat

Джерело даних

Ogranicz do:

Dostawca treści

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji

Початок дослідження:

Multiple myeloma.